Immucell (ICCC) Free Cash Flow Growth (3y) (2013 - 2025)
Powered by 
Analysis
Immucell (ICCC) Free Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.36 Bn | 40.16 Bn | 779.09 Mn | 23.11% |
| 2 | Zoetis | 29.60 Bn | 27.92 Bn | 1.05 Bn | 216.31% |
| 3 | Elanco Animal Health | 11.20 Bn | 10.67 Bn | 798.00 Mn | 134.18% |
| 4 | Phibro Animal Health | 1.40 Bn | 1.32 Bn | 134.40 Mn | -17.62% |
| 5 | Immucell | 90.37 Mn | 81.51 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.93 Mn | 65.85 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -139.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 28.29% |
| Sep 30, 2025 | 3.75% |
| Jun 30, 2025 | 65.56% |
| Mar 31, 2025 | 110.80% |
| Dec 31, 2024 | -19.52% |
| Sep 30, 2024 | -20.45% |
| Jun 30, 2024 | 72.93% |
| Mar 31, 2024 | 33.10% |
| Dec 31, 2023 | -84.33% |
| Sep 30, 2023 | 24.31% |
| Jun 30, 2023 | -145.98% |
| Mar 31, 2023 | -105.88% |
| Dec 31, 2022 | -55.74% |
| Sep 30, 2022 | -62.27% |
| Jun 30, 2022 | -9.30% |
| Mar 31, 2022 | -32.95% |
| Dec 31, 2021 | 21.04% |
| Sep 30, 2021 | 16.76% |
| Jun 30, 2021 | 80.74% |
| Mar 31, 2021 | -0.32% |